Literature DB >> 22135076

Determining the modified Rankin score after stroke by postal and telephone questionnaires.

Martin Dennis1, Gillian Mead, Fergus Doubal, Catriona Graham.   

Abstract

BACKGROUND AND
PURPOSE: The modified Rankin Scale (mRS) is the most common outcome measure in large randomized controlled trials in stroke. We tested 2 postal mRS questionnaires and a telephone questionnaire to determine completion rates and intermodality agreement.
METHODS: We sent postal questionnaires containing 2 versions of the mRS to surviving stroke patients. One version, tick box, involved the patient/proxy ticking 1 of the 5 descriptions equating to mRS scores; the other, the simplified modified Rankin questionnaire (smRSq), included 5 questions with yes/no responses from which the mRS is derived. We performed a semistructured telephone interview to consenting respondents, blinded to postal responses, to assign an mRS. We compared the mRS obtained by these different methods.
RESULTS: We sent questionnaires to 343 of 356 surviving patients (96%) and received 225 responses (66%). The mRS could not be derived in 27 respondents (12%) and 10 respondents (4%) on the tick box and smRSq, respectively (difference in proportion, 8% [95% CI, 3-13]. One hundred three of 190 respondents (54%) to the postal questionnaire agreed on the tick box versus smRSq version (κ=0.44 [0.38, 0.50]). Agreements between the tick box versus telephone and smRSq versus telephone were 57% (ie, 87/152, κ=0.47 [0.40, 0.55], and 64% (ie, 104/161, κ=0.55 [0.47, 0.62], respectively.
CONCLUSIONS: In large studies where face-to-face assessment of mRS is impractical, a postal smRSq with telephone follow-up to nonresponders will achieve higher levels of follow-up than will the tick box version and also good levels of intermodality agreement with least risk of bias.

Entities:  

Mesh:

Year:  2011        PMID: 22135076     DOI: 10.1161/STROKEAHA.111.639708

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  21 in total

1.  Dichotomous "Good Outcome" Indicates Mobility More Than Cognitive or Social Quality of Life.

Authors:  Andrew M Naidech; Jennifer L Beaumont; Michael Berman; Brandon Francis; Eric Liotta; Matthew B Maas; Shyam Prabhakaran; Jane Holl; David Cella
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

2.  Fluoxetine to improve functional outcomes in patients after acute stroke: the FOCUS RCT.

Authors:  Martin Dennis; John Forbes; Catriona Graham; Maree Hackett; Graeme J Hankey; Allan House; Stephanie Lewis; Erik Lundström; Peter Sandercock; Gillian Mead
Journal:  Health Technol Assess       Date:  2020-05       Impact factor: 4.014

3.  Web-Based Assessment of Outcomes After Subarachnoid and Intracerebral Hemorrhage: A New Patient Centered Option for Outcomes Assessment.

Authors:  Andrew M Naidech; Jennifer L Beaumont; Michael Berman; Eric Liotta; Matthew B Maas; Shyam Prabhakaran; Konrad Kording; Jane Holl; David Cella
Journal:  Neurocrit Care       Date:  2015-08       Impact factor: 3.210

4.  The impact of early-life intelligence quotient on post stroke cognitive impairment.

Authors:  Stephen Dj Makin; Fergus N Doubal; Kirsten Shuler; Francesca M Chappell; Julie Staals; Martin S Dennis; Joanna M Wardlaw
Journal:  Eur Stroke J       Date:  2018-01-08

5.  Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients With Hypertension Aged 80 Years and Older: The OPTIMISE Randomized Clinical Trial.

Authors:  James P Sheppard; Jenni Burt; Mark Lown; Eleanor Temple; Rebecca Lowe; Rosalyn Fraser; Julie Allen; Gary A Ford; Carl Heneghan; F D Richard Hobbs; Sue Jowett; Shahela Kodabuckus; Paul Little; Jonathan Mant; Jill Mollison; Rupert A Payne; Marney Williams; Ly-Mee Yu; Richard J McManus
Journal:  JAMA       Date:  2020-05-26       Impact factor: 56.272

6.  Ocular pain and discomfort after advanced surface ablation: an ignored complaint.

Authors:  Eva M Sobas; Sebastián Videla; Miguel J Maldonado; Jose C Pastor
Journal:  Clin Ophthalmol       Date:  2015-09-04

7.  Effect of thrombolysis with alteplase within 6 h of acute ischaemic stroke on long-term outcomes (the third International Stroke Trial [IST-3]): 18-month follow-up of a randomised controlled trial.

Authors: 
Journal:  Lancet Neurol       Date:  2013-06-21       Impact factor: 44.182

8.  Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice.

Authors:  David J Seiffge; Christopher Traenka; Alexandros A Polymeris; Sebastian Thilemann; Benjamin Wagner; Lisa Hert; Mandy D Müller; Henrik Gensicke; Nils Peters; Christian H Nickel; Christoph Stippich; Raoul Sutter; Stephan Marsch; Urs Fisch; Raphael Guzman; Gian Marco De Marchis; Philippe A Lyrer; Leo H Bonati; Dimitrios A Tsakiris; Stefan T Engelter
Journal:  J Stroke       Date:  2017-09-06       Impact factor: 6.967

9.  The stroke oxygen pilot study: a randomized controlled trial of the effects of routine oxygen supplementation early after acute stroke--effect on key outcomes at six months.

Authors:  Khalid Ali; Anushka Warusevitane; Frank Lally; Julius Sim; Sheila Sills; Sarah Pountain; Tracy Nevatte; Martin Allen; Christine Roffe
Journal:  PLoS One       Date:  2013-06-03       Impact factor: 3.240

10.  The FOCUS, AFFINITY and EFFECTS trials studying the effect(s) of fluoxetine in patients with a recent stroke: a study protocol for three multicentre randomised controlled trials.

Authors:  Gillian Mead; Maree L Hackett; Erik Lundström; Veronica Murray; Graeme J Hankey; Martin Dennis
Journal:  Trials       Date:  2015-08-20       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.